SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hammack, B N
Right arrow Articles by Gilden, D H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammack, B N
Right arrow Articles by Gilden, D H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Improved resolution of human cerebrospinal fluid proteins on two-dimensional gels

B N Hammack

Department of Neurology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA, barbara.hammack{at}uchsc.edu

G P Owens

Department of Neurology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA

M P Burgoon

Department of Neurology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA

D H Gilden

Department of Neurology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA, Department of Microbiology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA

Proteomics combines two-dimensional gel electro phoresis and peptide mass fingerprinting and can potentially identify a protein(s) unique to disease. Such proteins can be used either for diagnosis or may be relevant to the pathogenesis of disease. Because patients with multiple sclerosis (MS) have increased amounts of immunoglobulin (Ig) G in their cerebrospinal fluid (C SF) that is directed against an as yet unidentified protein, we are applying proteomics to MS C SF, studies that require optimal separation of proteins in human C SF. We found that recovery of proteins from C SF of MS patients was improved using ultrafiltration, rather than dialysis, for desalting. Resolution of these proteins was enhanced by aceto ne precipitatio n of desalted C SF before electrophoresis and by fractionation of C SF using C ibacron Blue sepharose affinity chromatography. Improved protein recovery and resolution will facilitate excision from gels for analysis by peptide mass fingerprinting.

Key Words: cerebrospinal fiuid • protein purification • multiple sclerosis

Multiple Sclerosis, Vol. 9, No. 5, 472-475 (2003)
DOI: 10.1191/1352458503ms954oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement